Clinical Commissioning Policy Statement: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent para-aortic tumours (All ages)

Document first published:
Page updated:
Topic:
Publication type:

Stereotactic ablative radiotherapy (SABR) is not recommended to be available as a treatment option for patients with previously irradiated, locally recurrent para-aortic tumours.

Document

Clinical Commissioning Policy Statement: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent para-aortic tumours (All ages)

Clinical Commissioning Policy Statement: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent para-aortic tumours (All ages)

  • PDF
  • 39 KB
  • 2 pages

Document

Evidence review: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent para-aortic tumours (All ages)

Evidence review: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent para-aortic tumours (All ages)

  • PDF
  • 909 KB
  • 57 pages

Document

Engagement report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent para-aortic tumours (All ages)

Engagement report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent para-aortic tumours (All ages)

  • PDF
  • 141 KB
  • 5 pages

Document

Commissioning through Evaluation report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent para-aortic tumours (All ages)

Commissioning through Evaluation report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent para-aortic tumours (All ages)

  • PDF
  • 3 MB
  • 329 pages

Document

CPAG summary report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent para-aortic tumours (All ages)

CPAG summary report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent para-aortic tumours (All ages)

  • PDF
  • 90 KB
  • 3 pages

Document

Equality and Health Inequalities Impact Assessment (EHIA): Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent para-aortic tumours (All ages)

Equality and Health Inequalities Impact Assessment (EHIA): Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent para-aortic tumours (All ages)

  • PDF
  • 129 KB
  • 10 pages

Document

Clinical panel report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent para-aortic tumours (All ages)

Clinical panel report: Stereotactic ablative radiotherapy (SABR) for patients with previously irradiated, locally recurrent para-aortic tumours (All ages)

  • PDF
  • 71 KB
  • 2 pages